A phase I study to evaluate the safety, tolerability, and pharmacokinetics of HEC113995PA·H(2)O, a novel dual-acting serotonergic antidepressant, in healthy subjects
一项I期研究旨在评估新型双效血清素能抗抑郁药HEC113995PA·H₂O在健康受试者中的安全性、耐受性和药代动力学。
期刊:Frontiers in Pharmacology
影响因子:4.8
doi:10.3389/fphar.2025.1500974
Wu, Xue; Wu, Qingqing; Ding, Qichen; Zhuang, Yulei; Luo, Lin; Zhang, Yingjun; Deng, Li; Jin, Chuanfei; Li, Xue; Huang, Zhangma; Qin, Haiping; Xin, Liang; Chen, Qian; Jia, Jingying; Liu, Yanmei